Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study

INTRODUCTION: Oral anticoagulant therapy, such as vitamin K antagonists (VKAs), is prominent for the prevention of cerebral ischemic stroke or systemic embolism and all-cause mortality in patients with atrial fibrillation, venous thromboembolism, and mechanical or biological valve. VKA treatment req...

Descripción completa

Detalles Bibliográficos
Autores principales: De Iuliis, Vincenzo, Ursi, Sebastiano, Vitullo, Gianfranco, Griffo, Irma, Marino, Antonio, Caruso, Marika, Cipollone, Francesco, Capodifoglio, Sabrina, Breda, Veronica, Toniato, Elena, Pennelli, Alfonso, Conti, Pio, Martinotti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688967/
https://www.ncbi.nlm.nih.gov/pubmed/28526929
http://dx.doi.org/10.1007/s40119-017-0090-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688967/
https://www.ncbi.nlm.nih.gov/pubmed/28526929
http://dx.doi.org/10.1007/s40119-017-0090-x

Ejemplares similares